In adherence to strict Non-Disclosure Agreements, Sedulo is unable to disclose identifiable information regarding our clients.
To support a successful oncology product rollout, Sedulo implemented a fully integrated CI program. Designed for launch-readiness, it provided real-time, actionable insights across commercialization stages, from competitive launches to positioning strategy, helping the client stay steps ahead of industry shifts
The Situation A European telecom provider engaged Sedulo Group to conduct research on the sales, offering, and distribution footprint of a telecommunications product across more than 30 European countries. The client needed to determine: Whether the product was being offered or installed in specific European markets, with priority placed on the Netherlands, Germany, and Belgium. Whether any Dutch entities (subsidiaries
Background A leading medical aesthetics company sought to prepare for a significant competitive disruption: the anticipated entry of a rival global manufacturer into the U.S. market. The client understood that this competitor’s entry would be accompanied by assertive marketing, differentiated product claims, and a well-funded commercial strategy, threatening to erode its market share and customer loyalty. To defend its position
A global HCM leader partnered with Sedulo to benchmark total cost of ownership (TCO) and ROI, fortifying its market offer against competitors. Our validated intelligence enabled the client to refine messaging, pricing, and value proposition, driving accelerated growth and outperforming the competition
Sedulo strengthened a digital solutions firm’s positioning with a targeted Voice‑of‑Customer Loss Survey. The program combined quantitative and qualitative intelligence to uncover decision criteria, competitor perceptions, and customer pain points, resulting in insights that directly informed product and messaging strategies
Background A leading health information technology network, operating within a dynamic and innovation-driven healthcare ecosystem, needed greater visibility into how its top competitors were evolving. The organization was facing heightened market complexity, with peer companies expanding service portfolios in areas such as Prior Authorization, Specialty Medications, and Real-Time Prescription Benefits. Leadership sought to address several critical strategic questions: What capabilities
